Align Technology (ALGN) Cash from Investing Activities (2009 - 2026)
Align Technology (ALGN) posted quarterly Cash from Investing Activities of -$131.6 million for Q1 2026, down 420.31% year-over-year from $41.1 million in Q1 2025, and down 266.36% quarter-over-quarter from -$35.9 million in Q4 2025.
Align Technology (ALGN) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Cash from Investing Activities for 18 consecutive years, with -$131.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 420.31% year-over-year to -$131.6 million; the TTM figure through Mar 2026 stood at -$218.7 million (down 9.03% YoY), while the FY2025 annual figure was -$112.4 million, up 55.89% from the prior year.
- Cash from Investing Activities eased to -$131.6 million in Q1 2026 per ALGN's latest filing, from -$35.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $18.1 million in Q2 2022 and bottomed at -$131.6 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$53.4 million across 5 years, with a median of -$52.8 million in 2023.
- On a YoY basis, Cash from Investing Activities climbed as much as 114.1% in 2022 and fell as far as 2075.43% in 2022.
- Align Technology's Cash from Investing Activities stood at -$55.8 million in 2022, then jumped by 76.13% to -$13.3 million in 2023, then sank by 304.65% to -$53.9 million in 2024, then soared by 33.39% to -$35.9 million in 2025, then tumbled by 266.36% to -$131.6 million in 2026.
- Business Quant data shows ALGN's Cash from Investing Activities at -$131.6 million in Q1 2026, -$35.9 million in Q4 2025, and -$19.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -82.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82.16 Mn |
| Jun 30, 2026 | -82.16 Mn |
| Mar 31, 2026 | -131.58 Mn |
| Mar 31, 2026 | -131.58 Mn |
| Dec 31, 2025 | -35.92 Mn |
| Dec 31, 2025 | -35.92 Mn |
| Sep 30, 2025 | -19.76 Mn |
| Sep 30, 2025 | -19.76 Mn |
| Jun 30, 2025 | -31.48 Mn |
| Jun 30, 2025 | -31.48 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Dec 31, 2024 | -53.92 Mn |
| Dec 31, 2024 | -53.92 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | -112.49 Mn |
| Jun 30, 2024 | -112.49 Mn |
| Mar 31, 2024 | -79.58 Mn |
| Mar 31, 2024 | -79.58 Mn |